Hospira, Inc. Recalls — U.S. Recall Records

Recall history in this database

Classification mix: Class II: 110, Class I: 31, Class III: 10.

DrugSep 26, 2012

Cytarabine Injection, 20 mg/mL, 50 mL Single Dose Vial recall — FDA D-1680-2012

The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass…

Class IIFDA: TerminatedHospira Inc.

DrugSep 5, 2012

Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial recall — FDA D-1672-2012

Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.

Class IIFDA: TerminatedHospira Inc.

DrugAug 22, 2012

Carboplatin Injection, 10 mg/mL, a) 5 mL multi-dose vials (NDC 61703-339-18) recall — FDA D-1648-2012

Failed PH specification: The lots of Carboplatin Injection were manufactured from Carboplatin API lots which trended out of specification low pH.

Class IIIFDA: TerminatedHospira Inc.

DrugAug 15, 2012

HYDROmorphone HCl Injection, USP, 1 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled recall — FDA D-1444-2012

Superpotent (Single Ingredient) Drug: Some of the prefilled cartridge units have been found to be overfilled and contain more than the 1 mL labeled fill volume.

Class IFDA: TerminatedHospira Inc.

DrugJul 25, 2012

Hospira Morphine Sulfate Injection, USP, 4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartridge recall — FDA D-1419-2012

Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL

Class IFDA: TerminatedHospira Inc.

DrugJun 27, 2012

Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL recall — FDA D-1390-2012

Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.

Class IIIFDA: TerminatedHospira, Inc.

DrugJun 20, 2012

Propofol Injectable Emulsion, 1%, (10mg/mL) recall — FDA D-1382-2012

Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel

Class IIFDA: TerminatedHospira, Inc.

Understanding this recall history

This page summarizes recall records in which the official source identifies Hospira, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.